stoxline Quote Chart Rank Option Currency Glossary
  
Oscar Health, Inc. (OSCR)
13.46  0.4 (3.06%)    02-14 16:00
Open: 13.56
High: 13.8
Volume: 3,230,420
  
Pre. Close: 13.06
Low: 13.235
Market Cap: 2,850(M)
Technical analysis
2025-02-14 4:50:24 PM
Short term     
Mid term     
Targets 6-month :  18.22 1-year :  20.51
Resists First :  15.6 Second :  17.55
Pivot price 15.3
Supports First :  12.43 Second :  10.34
MAs MA(5) :  13.82 MA(20) :  15.52
MA(100) :  16.15 MA(250) :  16.93
MACD MACD :  -0.5 Signal :  -0.1
%K %D K(14,3) :  13.5 D(3) :  10.6
RSI RSI(14): 37.9
52-week High :  23.79 Low :  12.43
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ OSCR ] has closed above bottom band by 14.3%. Bollinger Bands are 12.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 13.81 - 13.89 13.89 - 13.97
Low: 13.04 - 13.14 13.14 - 13.23
Close: 13.31 - 13.45 13.45 - 13.59
Company Description

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Headline News

Sun, 16 Feb 2025
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Sun, 16 Feb 2025
Oscar Health (NYSE:OSCR) Sets New 12-Month Low - Should You Sell? - MarketBeat

Fri, 14 Feb 2025
Oscar Health (NYSE:OSCR) Reaches New 1-Year Low - Here's Why - MarketBeat

Thu, 13 Feb 2025
Oscar Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OSCR - PR Newswire

Thu, 13 Feb 2025
Oscar Health: Looking Like A Cheap High-Growth Company, But Not Without A Catch - Seeking Alpha

Sat, 08 Feb 2025
Oscar Health, Inc. (OSCR) Among the Best Health Insurance Stocks to Buy in 2025 - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 212 (M)
Shares Float 190 (M)
Held by Insiders 3 (%)
Held by Institutions 90.1 (%)
Shares Short 19,750 (K)
Shares Short P.Month 19,540 (K)
Stock Financials
EPS -0.02
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.71
Profit Margin 0.3 %
Operating Margin -2 %
Return on Assets (ttm) 0.2 %
Return on Equity (ttm) 2.8 %
Qtrly Rev. Growth 68.3 %
Gross Profit (p.s.) 8.21
Sales Per Share 38.81
EBITDA (p.s.) 0.2
Qtrly Earnings Growth 0 %
Operating Cash Flow 928 (M)
Levered Free Cash Flow 1,440 (M)
Stock Valuations
PE Ratio -673
PEG Ratio 0
Price to Book value 2.85
Price to Sales 0.34
Price to Cash Flow 3.07
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android